A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market
A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market
22-Feb-2012
North America
$1,500.00
Special Price $1,125.00 save 25 %
Description
This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90 to 95 percent of diabetes patients suffer from type 2 diabetes mellitus. The purpose of this study is to highlight the current market landscape, and provide a competitive analysis of all marketed and pipeline drugs in development for type 2 diabetes mellitus. Dashboard slides are provided for all marketed and Phase 3 drugs in development for type 2 diabetes mellitus.
Table of Contents
Research Service
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9837-00-33-00-00 |
Is Prebook | No |